Phase II study of zevorcabtagene autoleucel, a fully human BCMA-targeting CAR T cell therapy, in patients with relapsed/refractory multiple myeloma. - Chen, Wenming; Fu, Chengcheng; Fang, Baijun; Liang, Aibin; Xia, Zhongjun; He, Yanjuan; Lu, Jin; Liu, Hui; Hou, Ming; Cai, Zhen; Yang, Wei; Hao, Siguo; et al. (Experimental Hematology & Oncology, 2025)